Top Markets
Coin of the day
Skye Bioscience, Inc. Skye Bioscience, Inc.

Skye Bioscience, Inc.

SKYE
Rang in Aktien #31353
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on... Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
Aktienkurs
$0.4018
Marktkapitalisierung
$14.12M
Veränderung (1 Tag)
-3.20%
Veränderung (1 Jahr)
-88.15%
Land
US
Handel Skye Bioscience, Inc. (SKYE)

Kategorie

Kursverlauf für Skye Bioscience, Inc. (SKYE)
Höchster Schlusskurs: $0.50 am 2026-08-01

Niedrigster Schlusskurs: $2.50K am 2014-11-01
Kursverlauf der Aktie von Skye Bioscience, Inc. von 2014 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 27.56%
2025 -68.43%
2024 7.82%
2023 -19.28%
2022 -74.81%
2021 58.02%
2020 -81.19%
2019 -44.44%
2018 157.69%
2017 -64.63%
2016 -42.36%
2015 -92.76%
2014 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$532.21 36.51%
US
$1.00K 51.44%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE